new glp 1 receptor agonists Molecules and Emerging Indications for GLP-1 Medicines Color coding... Current Insights, Advantages and Challenges

GLP-1 medications can provide major health benefits, but recent studies have raised questions about a possible link with NAION, a rare optic nerve condition that can cause sudden vision loss

SAN DIEGO(March 10, 2025)Glucagon-like peptide-1 receptor agonists (GLP-1 agonists), such as semaglutide (e.g., Ozempic), have helped improve the management of type 2 diabetes and obesity

Semaglutide: Tirzepatide is a dual agonist for GLP-1 and GIP receptors

GLP-1 RAs have been shown to result in increased residual gastric contents (RGCs) in patients undergoing EGDs and poor Boston Bowel Preparation Scores (BBPSs) in those undergoing colonoscopies

Ozempic changed the conversation around weight loss in a way that almost nothing has in the past twenty years

Those who took Ozempic or a similar drug had a 40% lower chance of overdosing on opioids and a 50% lower chance of getting drunk compared to those who didn't take the medication, the study found.